Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The P2Y12 purinoceptor is a G protein-coupled receptor primarily functioning as a chemoreceptor for ADP, mediating platelet aggregation. It is a key regulator of hemostasis and thrombosis and is expressed on platelets and microglia. It is a target for antiplatelet therapy in thromboembolic diseases. Genetic polymorphisms are associated with cardiovascular and neurological conditions.
Antagonism of P2Y12 receptor, inhibiting ADP-mediated platelet activation and aggregation
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Purinoceptor P2Y12 (P2Y12).